Supported by operational growth of 6.7%, Johnson & Johnson ( JNJ, Financials) reported a 5.3% rise in fourth-quarter revenues to $22.5 billion. With operational growth of 5.9% except for COVID-19 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback